A Phase 1b, Prospective, Multicenter, Randomized, Single Masked, Sham-Controlled Study to Assess the Safety, Tolerability and Evidence of Activity of a Single Intravitreal Injection of UBX1325 in Patients with Diabetic Macular Edema (DME)
Research Grant
Administered By
Ophthalmology
Awarded By
UNITY Biotechnology
Start Date
December 1, 2020
End Date
January 31, 2023
Administered By
Ophthalmology
Awarded By
UNITY Biotechnology
Start Date
December 1, 2020
End Date
January 31, 2023